Vaccination-Related Worsening of Disease in Patients with Immune-Mediated Inflammatory Diseases.

Authors

Katharina Meiszl, Robin Denz, Marianne Charlotte Tokic, Jale Basten, Romy Lauer, Heike van de Sand, Theresa Oganowski, Thomas Grüter, Stephanie Stock, Diplom Dusan Simic, Diplom Arim Shukri, Uta Kiltz, Maria Zacharopoulou, Horst Christian Vollmar, Ina Carola Otte, Chantal Flemm, Anastasia Suslow, Andreas Stallmach, Anika Franz, Ursula Marschall, Diplom Joachim Saam, Catharina Tiemann, Katja Reeb, Carolin Heinen, Ingo Meyer, Kerstin Hellwig, Nina Timmesfeld, VAC-MAC consortium

Published in

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. Pages 109012. Jul 25, 2026. Epub Jul 25, 2026.

Abstract

Vaccinations are important for patients with immune-mediated inflammatory diseases (IMID), including multiple sclerosis (MS), inflammatory rheumatic and musculoskeletal diseases (iRMD), or inflammatory bowel diseases (IBD). However, safety concerns persist regarding potential disease worsening. This study assessed the risk of IMID worsening requiring emergency hospitalization following pneumococcal or influenza vaccination.
In this retrospective population-based cohort study, six target trial emulations with time-dependent matching were performed using claims data from the German statutory health insurance BARMER from January 2013 to December 2019. Covariate-adjusted hazard ratios (HR) with 95% confidence intervals (CIs) were estimated using Cox proportional hazards models.
Of 432,768 IMID patients, 9,526 MS, 108,422 iRMD, and 19,238 IBD patients were included in pneumococcal trials, and 30,416 MS, 265,850 iRMD, and 53,056 IBD patients in influenza trials. No increased risk was found; instead, a trend towards risk reduction was observed. Pneumococcal trials showed HRs of 0.91 [95% CI 0.58-1.42] for MS, 0.60 [0.38-0.94] for iRMD, and 0.89 [0.62-1.26] for IBD. The influenza trials showed similar results (MS: 0.94 [0.73-1.21]; iRMD: 0.79 [0.63-1.00]; IBD: 0.83 [0.68-1.03]).
No evidence of increased IMID worsening requiring emergency hospitalization after pneumococcal or influenza vaccination was found, supporting the safety of immunizing these patients.

PMID:
42501818
Bibliographic data and abstract were imported from PubMed on 26 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.